OLYMPUS On-Demand Library
Medical Products and Solutions
Discover detailed information about medical products and solutions from Olympus.

Research Areas of Interest

Olympus Corporation is committed to advancing medical and scientific knowledge about Olympus products and contributing to the improvement of patient care by supporting investigator sponsored original research.

Urology

Bladder Cancer

・Detection of bladder tumor (especially CIS) using NBI of VISERA ELITE II

 

Urolithiasis

・Clinical performance of SOLTIVE (optimal laser  setting for various clinical settings)

・Clinical outcomes and healthcare economics of SOLTIVE compared with Ho:YAG laser

・Treatment outcomes of SOLTIVE in patients with stones greater than 2cm

 

Benign Prostatic Hyperplasia (BPH)

・Clinical performance of SOLTIVE (optimal laser setting for various clinical settings)

・Treatment outcomes of SOLTIVE in patients on anticoagulant medication

・Clinical outcomes of SOLTIVE compared with HoLEP and/or ThuLEP

Gynecology

 Uterine Fibroid

・Treatment outcomes of PLASMA compared with monopolar especially in patients with large and/or type 2 uterine fibroid

・Cost-effectiveness of PLASMA compared with mechanical morcellators

 

Office Procedure

・Clinical performance of Olympus products in office settings

Gastroenterology

Esophagus

・TXI or RDI better identifies level of GERD compared to WLI.

・NBI powered by LED increases detection rate of Barrett adenocarcinoma compared to WLI

・Endoluminal treatment outcomes of Olympus products

 

Stomach

・TXI increases detection rate of inflammatory diseases in stomach compared to WLI.

Colon

・ENDO-AID (CADe) increases the detection rate of colorectal cancer compared to WLI.

・TXI increases detection rate or decreases miss rate compared to 190 basis WLI.

・TXI, RDI or NBI increases accuracy of diagnosis of UC/CD and/or accuracy of scoring of UC/CD severity compared to WLI or conducting random biopsy.

・RDI, TXI or NBI increases detection rate of cancer in the surveillance of UC and/or CD patients compared to WLI.

・TXI, RDI or NBI increase interobserver agreement on severity scoring among endoscopists compared to WLI.

 

Treatment

・RDI increases clinical values such as shortening procedure time or increasing success rate of treatment in the urgent endoscopic procedures that have bleeding. (Welcome wider ideas)

Respiratory

 Lung Cancer

・Clinical outcomes especially diagnostic yield of hybrid bronchoscope (BF-MP190F) combined with PeriView FLEX

・Clinical outcomes of ultrasound bronchoscope (BF-UC190F/UC290F)

・Effectiveness of insertion tube rotation function and 210 degree angulation in clinical settings (BF-XP190/290, BF-P190/290, BF-Q190/290, BF-H190/290, BF-MP190/290)

Neurosurgery

 Brain and Spinal Cord Tumor Surgery

・Utilization of exoscope (ORBEYE)

 

Contact Form (For European resident)